Akèy › Maladi Parkinson
Etid klinik pou Maladi Parkinson ap rekrite nan Etazini
209 etid pou Maladi Parkinson ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY24 etid
- Boston, MA20 etid
- Cleveland, OH18 etid
- Minneapolis, MN17 etid
- Nashville, TN16 etid
- San Francisco, CA15 etid
- Philadelphia, PA15 etid
- Miami, FL14 etid
- Farmington Hills, MI14 etid
- New Haven, CT14 etid
- Chicago, IL14 etid
- Charleston, SC13 etid
- Gainesville, FL13 etid
- Tampa, FL12 etid
- Atlanta, GA12 etid
- Aurora, CO12 etid
- Portland, OR12 etid
- Orlando, FL11 etid
- Birmingham, AL11 etid
- Washington, DC11 etid
- Los Angeles, CA10 etid
- Round Rock, TX10 etid
- Durham, NC10 etid
- Houston, TX10 etid
- Ann Arbor, MI10 etid
- Dallas, TX9 etid
- Kirkland, WA9 etid
- Baltimore, MD9 etid
- Mountain View, CA9 etid
- St. Louis, MO9 etid
- Boca Raton, FL9 etid
- Kansas City, KS9 etid
- Spokane, WA7 etid
- Phoenix, AZ7 etid
- Las Vegas, NV7 etid
- Lexington, KY6 etid
- Pittsburgh, PA6 etid
- Columbus, OH6 etid
- Seattle, WA6 etid
- San Diego, CA6 etid
Pa eta
- Alabama12 etid
- Arizona13 etid
- Arkansas5 etid
- Colorado18 etid
- Connecticut19 etid
- Delaware3 etid
- Distrik Columbia5 etid
- Florid35 etid
- Georgia13 etid
- Illinois19 etid
- Indiana5 etid
- Iowa4 etid
- Kalifòni37 etid
- Kansas11 etid
- Kentucky9 etid
- Lwizyàn3 etid
- Maryland15 etid
- Massachusetts21 etid
- Michigan22 etid
- Minnesota19 etid
- Missouri10 etid
- Nevada7 etid
- New Jersey3 etid
- New Mexico5 etid
- New York32 etid
- North Carolina15 etid
- Ohio25 etid
- Oklahoma4 etid
- Oregon12 etid
- Pennsylvania19 etid
- South Carolina13 etid
- Tennessee19 etid
- Texas27 etid
- Utah6 etid
- Vermont4 etid
- Virginia10 etid
- Washington16 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Visual Hallucinations in Lewy Body Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT07849413Evaluation and Treatment of Neurosurgical Disorders
Ap rekriteEtid obsèvasyon
Laj 4 a 99 · Tout sèks · Mizajou Sep 29, 2026 · NCT00060541Deep Brain Stimulation Therapy in Movement Disorders
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Sep 29, 2026 · NCT02119611Bayesian Optimization of DBS for Gait
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07835308A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Ap rekriteFaz 2/3
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT06976268The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT07610369GBPDC: Gut-Brain in PD Consortium Master Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07567794Speech Learning and Speech Production in Parkinson's Disease
Ap rekrite
Laj 45 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07403539This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07830654Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07005180A Study of Buntanetap in Participants With PD
Ap rekriteFaz 2/3
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07056361RESvEraTrol in Parkinson's Disease (RESET)
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT07592767PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Sep 18, 2026 · NCT04396873Natural History Protocol for Movement Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 100 · Tout sèks · Mizajou Sep 18, 2026 · NCT05413291Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT02071134Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT01734122Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
Ap rekrite
Laj 50 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07534397Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator
Ap rekrite
Laj 25 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07682311Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07398157Dual Frequency Stimulation in Parkinson's Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04650932A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Ap rekriteFaz 2
Laj 50 a 90 · Tout sèks · Mizajou Sep 11, 2026 · NCT06638944A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Ap rekriteFaz 2
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04994015Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.